Neoadjuvant immunotherapy combined with chemotherapy for local advanced non-small cell lung cancer: a case report

Immunotherapy has revolutionized lung cancer management and revitalized the field of tumor immunology. Anti-programmed death 1 (anti-PD-1) immunotherapy can significantly improve the survival of patients with advanced non-small cell lung cancer (NSCLC), but its role in neoadjuvant therapy of local a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jie, Xia, Haoran, Sun, Fenghuan, Zhang, Peng, Jiang, Gening
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106098/
https://www.ncbi.nlm.nih.gov/pubmed/33987422
http://dx.doi.org/10.21037/atm-21-1565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106098/
https://www.ncbi.nlm.nih.gov/pubmed/33987422
http://dx.doi.org/10.21037/atm-21-1565

Ejemplares similares